Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence

  • Read more about Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence
South Korea
1020087010596
Filed on 2006-09-29

A Prognostic Gene Expression Signature Predicting For Survival In Patients With Advanced Stage Ovarian Cancer That Includes A Novel Modulator Of Ovarian Tumor And Endothelial Cell Behavior

  • Read more about A Prognostic Gene Expression Signature Predicting For Survival In Patients With Advanced Stage Ovarian Cancer That Includes A Novel Modulator Of Ovarian Tumor And Endothelial Cell Behavior
Patent Cooperation Treaty
PCT/US2008/070565
Filed on 2008-07-19

Molecular Grading Methods

  • Read more about Molecular Grading Methods
Patent Cooperation Treaty
PCT/US08/007699
Filed on 2008-06-20

A Novel Chemical Compound That Binds Tubulin And Also Binds A Steroid Hormone Receptor

  • Read more about A Novel Chemical Compound That Binds Tubulin And Also Binds A Steroid Hormone Receptor
Patent Cooperation Treaty
PCT/US2008/008299
Filed on 2008-07-02

Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use

  • Read more about Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use
European Patent
06838737.2
Filed on 2006-12-01

Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use

  • Read more about Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use
US Patent 8,088,729
Filed on 2008-05-30

SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN

  • Read more about SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN
US Application 12/087,306
Filed on 2008-07-01

Soluble Forms Of The SARS Virus S Protein

  • Read more about Soluble Forms Of The SARS Virus S Protein
European Patent
07718249.1
Filed on 2007-01-19

SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN

  • Read more about SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN
China
200780002688.5
Filed on 2007-01-19

Soluble Forms Of The SARS Virus S Protein

  • Read more about Soluble Forms Of The SARS Virus S Protein
Canada
2637730
Filed on 2007-01-19

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 885
  • Page 886
  • Page 887
  • Page 888
  • Page 889
  • Page 890
  • Page 891
  • Page 892
  • Page 893
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health